rs4378657

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_018129.4(PNPO):​c.552G>A​(p.Leu184=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0738 in 1,610,284 control chromosomes in the GnomAD database, including 4,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 366 hom., cov: 32)
Exomes 𝑓: 0.075 ( 4567 hom. )

Consequence

PNPO
NM_018129.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.967
Variant links:
Genes affected
PNPO (HGNC:30260): (pyridoxamine 5'-phosphate oxidase) The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 17-47946328-G-A is Benign according to our data. Variant chr17-47946328-G-A is described in ClinVar as [Benign]. Clinvar id is 129983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-47946328-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.967 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0821 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PNPONM_018129.4 linkuse as main transcriptc.552G>A p.Leu184= synonymous_variant 6/7 ENST00000642017.2 NP_060599.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PNPOENST00000642017.2 linkuse as main transcriptc.552G>A p.Leu184= synonymous_variant 6/7 NM_018129.4 ENSP00000493302 P1Q9NVS9-1

Frequencies

GnomAD3 genomes
AF:
0.0636
AC:
9668
AN:
152080
Hom.:
365
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0315
Gnomad AMI
AF:
0.0297
Gnomad AMR
AF:
0.0585
Gnomad ASJ
AF:
0.0985
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0886
Gnomad FIN
AF:
0.0915
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0812
Gnomad OTH
AF:
0.0728
GnomAD3 exomes
AF:
0.0685
AC:
17168
AN:
250688
Hom.:
738
AF XY:
0.0721
AC XY:
9775
AN XY:
135578
show subpopulations
Gnomad AFR exome
AF:
0.0311
Gnomad AMR exome
AF:
0.0413
Gnomad ASJ exome
AF:
0.0935
Gnomad EAS exome
AF:
0.000272
Gnomad SAS exome
AF:
0.0947
Gnomad FIN exome
AF:
0.0864
Gnomad NFE exome
AF:
0.0803
Gnomad OTH exome
AF:
0.0733
GnomAD4 exome
AF:
0.0749
AC:
109163
AN:
1458086
Hom.:
4567
Cov.:
30
AF XY:
0.0764
AC XY:
55453
AN XY:
725534
show subpopulations
Gnomad4 AFR exome
AF:
0.0278
Gnomad4 AMR exome
AF:
0.0430
Gnomad4 ASJ exome
AF:
0.0939
Gnomad4 EAS exome
AF:
0.000252
Gnomad4 SAS exome
AF:
0.0972
Gnomad4 FIN exome
AF:
0.0873
Gnomad4 NFE exome
AF:
0.0777
Gnomad4 OTH exome
AF:
0.0675
GnomAD4 genome
AF:
0.0636
AC:
9673
AN:
152198
Hom.:
366
Cov.:
32
AF XY:
0.0628
AC XY:
4676
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.0316
Gnomad4 AMR
AF:
0.0584
Gnomad4 ASJ
AF:
0.0985
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.0891
Gnomad4 FIN
AF:
0.0915
Gnomad4 NFE
AF:
0.0812
Gnomad4 OTH
AF:
0.0711
Alfa
AF:
0.0761
Hom.:
634
Bravo
AF:
0.0576
Asia WGS
AF:
0.0240
AC:
83
AN:
3478
EpiCase
AF:
0.0836
EpiControl
AF:
0.0769

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Pyridoxal phosphate-responsive seizures Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 02, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
11
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4378657; hg19: chr17-46023694; API